Escalon Medical Corp. (OTCMKTS:ESMC – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 29th, there was short interest totaling 83,822 shares, a decline of 51.0% from the May 14th total of 171,227 shares. Based on an average daily volume of 89,881 shares, the short-interest ratio is presently 0.9 days. Approximately 1.2% of the shares of the stock are short sold.
Escalon Medical Price Performance
Shares of Escalon Medical stock traded up $0.00 during trading on Monday, hitting $0.20. 899 shares of the stock traded hands, compared to its average volume of 25,471. The stock has a market cap of $1.48 million, a price-to-earnings ratio of 1.82 and a beta of 0.13. The company has a quick ratio of 1.94, a current ratio of 2.59 and a debt-to-equity ratio of 0.04. Escalon Medical has a 52 week low of $0.10 and a 52 week high of $0.42. The firm’s fifty day moving average is $0.19 and its 200-day moving average is $0.18.
Escalon Medical (OTCMKTS:ESMC – Get Free Report) last released its earnings results on Friday, May 15th. The medical equipment provider reported $0.16 earnings per share for the quarter. The company had revenue of $2.61 million during the quarter. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.
Escalon Medical Company Profile
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.
Read More
- Five stocks we like better than Escalon Medical
- Iran Ceasefire or Not, These 3 Companies Could Win
- Gold Is Testing Its 200-Day SMA—These 3 Mining Stocks Are the Play
- Summer Is Coming–But There’s No End in Sight for This Crypto Winter
- Oil Could Dip, But These 3 Energy Stocks Still Look Built to Win
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
